304129
Integrated trauma-informed services for minority women with co-occurring substance use and mental health disorders
Methods: From October 2013 to February 2014 baseline data were collected from 46 minority women participating in intensive outpatient treatment via the Preliminary Intake Assessment, Government Performance and Results Act instrument, and Rapid HIV Testing Clinical Information forms.
Results: Substance use disorder and self-reported co-occurring mental health diagnoses are concurrent with past 30 days experience of trouble understanding, concentrating, or remembering (68%); experienced serious anxiety (42%); experienced serious depression (42%); have been prescribed psychological medication (28%); and attempted suicide (6%). Additionally, 81% of respondents endorsed ever experienced violence or trauma; and 69% ever experienced serious psychological distress. Methamphetamine was the primary drug of choice for 41% of participants, and 62% of Latina participants. Sixty-nine percent of respondents reported previous substance abuse treatment, and 56% reported treatment during the last 12 months.
Conclusion: Targeted, integrated, and evidence-based services are needed to address the complexity of substance use disorder and co-occurring mental health needs of minority women. Methamphetamine remains a public health challenge for minority women, especially Latinas.
Learning Areas:
Administer health education strategies, interventions and programsDiversity and culture
Social and behavioral sciences
Learning Objectives:
Discuss co-occurring issues related to substance-using minority women.
Assess the benefit of providing integrated services to substance-using minority women.
Keyword(s): Drug Abuse, Minority Health
Qualified on the content I am responsible for because: I have been the Project Director/Principal Investigater of 2 SAMHSA grants since 2009, and have been working in the fields of substance abuse and HIV risk reduction since 2001. My interests include heatlh disparities, social determinants of health, substance-using women, and methamphetamine.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.